Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes
Details for Australian Patent Application No. 2009201979 (hide)
International Classifications
Event Publications
4 June 2009 Complete Application Filed
Priority application(s): 10-2008-0046335 19.05.08 KR
2 July 2009 Amendment Made
The nature of the amendment is: Amend the invention title to read Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes
3 December 2009 Application Open to Public Inspection
Published as AU-A-2009201979
16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009201980-Stabilized boehmite-derived catalyst supports, catalysts, methods of making and using
2009201978-Method and apparatus for determining a set of acceptable transport format combinations
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser